315 related articles for article (PubMed ID: 8916471)
1. Estrogens--pharmacokinetics and pharmacodynamics with special reference to vaginal administration and the new estradiol formulation--Estring.
Johnston A
Acta Obstet Gynecol Scand Suppl; 1996; 163():16-25. PubMed ID: 8916471
[TBL] [Abstract][Full Text] [Related]
2. Pharmacokinetic data on estradiol in light of the estring concept. Estradiol and estring pharmacokinetics.
Gabrielsson J; Wallenbeck I; Birgerson L
Acta Obstet Gynecol Scand Suppl; 1996; 163():26-31; discussion 32-4. PubMed ID: 8916472
[TBL] [Abstract][Full Text] [Related]
3. Effect of one-week treatment with vaginal estrogen preparations on serum estrogen levels in postmenopausal women.
Labrie F; Cusan L; Gomez JL; Côté I; Bérubé R; Bélanger P; Martel C; Labrie C
Menopause; 2009; 16(1):30-6. PubMed ID: 18820592
[TBL] [Abstract][Full Text] [Related]
4. Endometrial and vaginal effects of low-dose estradiol delivered by vaginal ring or vaginal tablet.
Weisberg E; Ayton R; Darling G; Farrell E; Murkies A; O'Neill S; Kirkegard Y; Fraser IS
Climacteric; 2005 Mar; 8(1):83-92. PubMed ID: 15804736
[TBL] [Abstract][Full Text] [Related]
5. A morphologist's approach to the vagina.
Forsberg JG
Acta Obstet Gynecol Scand Suppl; 1996; 163():3-10. PubMed ID: 8916469
[TBL] [Abstract][Full Text] [Related]
6. Alternatives to oral estrogen replacement. Transdermal patches, percutaneous gels, vaginal creams and rings, implants, other methods of delivery.
Baker VL
Obstet Gynecol Clin North Am; 1994 Jun; 21(2):271-97. PubMed ID: 7936545
[TBL] [Abstract][Full Text] [Related]
7. The effect of transdermal and vaginal estrogen therapy on markers of postmenopausal estrogen status.
Gupta P; Ozel B; Stanczyk FZ; Felix JC; Mishell DR
Menopause; 2008; 15(1):94-7. PubMed ID: 17882008
[TBL] [Abstract][Full Text] [Related]
8. Sexual dysfunction in the peri- and postmenopause. Status of incidence, pharmacological treatment and possible risks. A secondary publication.
Gregersen N; Jensen PT; Giraldi AE
Dan Med Bull; 2006 Aug; 53(3):349-53. PubMed ID: 17092454
[TBL] [Abstract][Full Text] [Related]
9. Treatment of postmenopausal vaginal atrophy with 10-μg estradiol vaginal tablets.
Panay N; Maamari R
Menopause Int; 2012 Mar; 18(1):15-9. PubMed ID: 22393176
[TBL] [Abstract][Full Text] [Related]
10. The pharmacokinetics and efficacy of different estrogens are not equivalent.
Ansbacher R
Am J Obstet Gynecol; 2001 Feb; 184(3):255-63. PubMed ID: 11228470
[TBL] [Abstract][Full Text] [Related]
11. TCPL delivery system as a model for E + P replacement therapy in post-ovariectomized adult rats mimicking a postmenopausal condition.
Cason Z; Benghuzzi H; Tucci M; England B
Biomed Sci Instrum; 2003; 39():529-34. PubMed ID: 12724947
[TBL] [Abstract][Full Text] [Related]
12. Bioavailability and pharmacodynamics of two 10-mg estradiol valerate depot formulations following IM single dose administration in healthy postmenopausal volunteers.
Schug BS; Donath F; Blume HH
Int J Clin Pharmacol Ther; 2012 Feb; 50(2):100-17. PubMed ID: 22257576
[TBL] [Abstract][Full Text] [Related]
13. Topical estrogen therapy in the management of postmenopausal vaginal atrophy: an up-to-date overview.
Al-Baghdadi O; Ewies AA
Climacteric; 2009 Apr; 12(2):91-105. PubMed ID: 19117185
[TBL] [Abstract][Full Text] [Related]
14. [Topical hormonal treatment and urogenital atrophy].
Sitruk-Ware R; Thomas JL
Praxis (Bern 1994); 1997 Aug; 86(33):1245-8. PubMed ID: 9381009
[TBL] [Abstract][Full Text] [Related]
15. Vulvovaginal atrophy: new and upcoming approaches.
Simon JA
Menopause; 2009; 16(1):5-7. PubMed ID: 19131842
[No Abstract] [Full Text] [Related]
16. Low-dose intravaginal estradiol delivery using a Silastic vaginal ring for estrogen replacement therapy in postmenopausal women: a review.
Sarkar NN
Eur J Contracept Reprod Health Care; 2003 Dec; 8(4):217-24. PubMed ID: 15006269
[TBL] [Abstract][Full Text] [Related]
17. Endometrial morphology during hormone replacement therapy with estradiol gel combined to levonorgestrel-releasing intrauterine device or natural progesterone.
Suvanto-Luukkonen E; Malinen H; Sundström H; Penttinen J; Kauppila A
Acta Obstet Gynecol Scand; 1998 Aug; 77(7):758-63. PubMed ID: 9740525
[TBL] [Abstract][Full Text] [Related]
18. Estradiol vaginal inserts (Imvexxy): effective in genitourinary syndrome of menopause without increasing systemic estrogen levels.
Paton DM
Drugs Today (Barc); 2018 Nov; 54(11):667-677. PubMed ID: 30539166
[TBL] [Abstract][Full Text] [Related]
19. Kinetics and pharmacology of estrogens in pre- and postmenopausal women.
Anderson F
Int J Fertil Menopausal Stud; 1993; 38 Suppl 1():55-64. PubMed ID: 8499960
[TBL] [Abstract][Full Text] [Related]
20. Efficacy of low-dose estradiol vaginal tablets in the treatment of atrophic vaginitis: a randomized controlled trial.
Bachmann G; Lobo RA; Gut R; Nachtigall L; Notelovitz M
Obstet Gynecol; 2008 Jan; 111(1):67-76. PubMed ID: 18165394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
